CHANGYI CHEN to Atherosclerosis
This is a "connection" page, showing publications CHANGYI CHEN has written about Atherosclerosis.
Connection Strength
1.006
-
Lysophosphatidic acid causes endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells. Atherosclerosis. 2012 May; 222(1):74-83.
Score: 0.211
-
Human protein S inhibits the uptake of AcLDL and expression of SR-A through Mer receptor tyrosine kinase in human macrophages. Blood. 2009 Jan 01; 113(1):165-74.
Score: 0.168
-
Ceramide: a common pathway for atherosclerosis? Atherosclerosis. 2008 Feb; 196(2):497-504.
Score: 0.157
-
Growth related oncogene-alpha (GRO-alpha): roles in atherosclerosis, angiogenesis and other inflammatory conditions. Med Sci Monit. 2007 Jun; 13(6):RA87-90.
Score: 0.153
-
Nitrotyrosine and chlorotyrosine: clinical significance and biological functions in the vascular system. J Surg Res. 2006 Jun 15; 133(2):143-9.
Score: 0.138
-
miRNAs: roles and clinical applications in vascular disease. Expert Rev Mol Diagn. 2011 Jan; 11(1):79-89.
Score: 0.049
-
Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. Am J Physiol Heart Circ Physiol. 2010 Jul; 299(1):H193-201.
Score: 0.047
-
Lactosylceramide promotes cell migration and proliferation through activation of ERK1/2 in human aortic smooth muscle cells. Am J Physiol Heart Circ Physiol. 2009 Jul; 297(1):H400-8.
Score: 0.044
-
C-reactive protein inhibits cholesterol efflux from human macrophage-derived foam cells. Arterioscler Thromb Vasc Biol. 2008 Mar; 28(3):519-26.
Score: 0.040